285 related articles for article (PubMed ID: 29976557)
21. Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.
Herrera AF; Chen L; Khajavian S; Chase M; Darrah J; Maloney D; Ho VT; Soiffer RJ; Antin JH; Forman SJ; Nademanee AP; Chen YB; Armand P; Shadman M
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2383-2387. PubMed ID: 31394277
[TBL] [Abstract][Full Text] [Related]
22. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.
Zhang C; Yi Y; Chen C; Wang J; Liu Z
Diagn Pathol; 2015 Dec; 10():215. PubMed ID: 26715530
[TBL] [Abstract][Full Text] [Related]
23. Emerging biological insights and novel treatment strategies in primary mediastinal large B-cell lymphoma.
Dunleavy K; Steidl C
Semin Hematol; 2015 Apr; 52(2):119-25. PubMed ID: 25805591
[TBL] [Abstract][Full Text] [Related]
24. Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics.
Ahmed Z; Afridi SS; Shahid Z; Zamani Z; Rehman S; Aiman W; Khan M; Mir MA; Awan FT; Anwer F; Iftikhar R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e865-e875. PubMed ID: 34330673
[TBL] [Abstract][Full Text] [Related]
25. Primary mediastinal large B-cell lymphoma.
Bhatt VR; Mourya R; Shrestha R; Armitage JO
Cancer Treat Rev; 2015 Jun; 41(6):476-85. PubMed ID: 25913715
[TBL] [Abstract][Full Text] [Related]
26. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.
Roberts RA; Wright G; Rosenwald AR; Jaramillo MA; Grogan TM; Miller TP; Frutiger Y; Chan WC; Gascoyne RD; Ott G; Muller-Hermelink HK; Staudt LM; Rimsza LM
Blood; 2006 Jul; 108(1):311-8. PubMed ID: 16543468
[TBL] [Abstract][Full Text] [Related]
27. Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.
Lees C; Keane C; Gandhi MK; Gunawardana J
Br J Haematol; 2019 Apr; 185(1):25-41. PubMed ID: 30740662
[TBL] [Abstract][Full Text] [Related]
28. Relapsed/refractory primary mediastinal large B-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices.
Takyar J; Raut M; Borse R; Balakumaran A; Sehgal M
Expert Rev Hematol; 2020 Mar; 13(3):275-287. PubMed ID: 31951774
[No Abstract] [Full Text] [Related]
29. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
30. Primary mediastinal B-cell lymphoma: update of its clinicopathologic features.
Paulli M; Lazzarino M; Gianelli U; Sträter E; Orlandi E; Klersy C; Viglio A; Rosso R; Gambacorta M; Rousset T; Morra E; Lavabre-Bertrand T; Bernasconi C; Manegold C; Magrini U; Möller P
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():115-23. PubMed ID: 9570688
[TBL] [Abstract][Full Text] [Related]
31. [Bone marrow involvement in primary mediastinal B-cell lymphoma].
Magomedova AU; Fastova EA; Kovrigina AM; Obukhova TN; Skidan NI; Mangasarova YK; Vorobyev AI; Kravchenko SK
Ter Arkh; 2017; 89(7):65-68. PubMed ID: 28766543
[TBL] [Abstract][Full Text] [Related]
32. Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria.
Hoppe BS; Advani R; Milgrom SA; Bakst RL; Ballas LK; Dabaja BS; Flowers CR; Ha CS; Mansur DB; Metzger ML; Pinnix CC; Plastaras JP; Roberts KB; Smith SM; Terezakis SA; Kirwan JM; Constine LS
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):36-44. PubMed ID: 33774076
[TBL] [Abstract][Full Text] [Related]
33. R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Shah NN; Szabo A; Huntington SF; Epperla N; Reddy N; Ganguly S; Vose J; Obiozor C; Faruqi F; Kovach AE; Costa LJ; Xavier AC; Okal R; Kanate AS; Ghosh N; Kharfan-Dabaja MA; Strelec L; Hamadani M; Fenske TS; Calzada O; Cohen JB; Chavez J; Svoboda J
Br J Haematol; 2018 Feb; 180(4):534-544. PubMed ID: 29265182
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
35. Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria.
Fairchild A; McCall CM; Oyekunle T; Niedzwiecki D; Champ C; McKinney M; Kelsey CR
Clin Lymphoma Myeloma Leuk; 2021 May; 21(5):e464-e469. PubMed ID: 33487576
[TBL] [Abstract][Full Text] [Related]
36. The molecular pathogenesis of primary mediastinal large B-cell lymphoma.
Steidl C; Gascoyne RD
Blood; 2011 Sep; 118(10):2659-69. PubMed ID: 21700770
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study between primary mediastinal B-cell lymphoma and non-mediastinal diffuse large B-cell lymphoma by immunoglobulin gene rearrangement and Epstein-Barr virus infection detection].
Zhong DR; Ling Q; Shi XH; Liang ZY; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):361-5. PubMed ID: 22932401
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.
Xu LM; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Liu QF; Chen B; Qi SN; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1289-95. PubMed ID: 23245279
[TBL] [Abstract][Full Text] [Related]
39. Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?
Giunta F; Zotta M; Menga M; Balma M; Bellò M; Passera R; Filippi AR; Chiappella A; Ladetto M; Ricardi U; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):214-9. PubMed ID: 25669764
[TBL] [Abstract][Full Text] [Related]
40. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
Jardin F; Pujals A; Pelletier L; Bohers E; Camus V; Mareschal S; Dubois S; Sola B; Ochmann M; Lemonnier F; Viailly PJ; Bertrand P; Maingonnat C; Traverse-Glehen A; Gaulard P; Damotte D; Delarue R; Haioun C; Argueta C; Landesman Y; Salles G; Jais JP; Figeac M; Copie-Bergman C; Molina TJ; Picquenot JM; Cornic M; Fest T; Milpied N; Lemasle E; Stamatoullas A; Moeller P; Dyer MJ; Sundstrom C; Bastard C; Tilly H; Leroy K
Am J Hematol; 2016 Sep; 91(9):923-30. PubMed ID: 27312795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
